Biotech giant Regeneron Pharmaceuticals, Inc. (REGN) is slated to report first-quarter 2025 results on April 29, 2025.The Zacks Consensus Estimate for revenues is pegged at $3.25 billion, while the same for earnings is pinned at$8.76 per share. (Find the latest earnings estimates and surprises on Zacks Earnings Calendar.)REGN’s Earnings Surprise HistoryThe company’s earnings beat estimates in three of the trailing four quarters and missed the same in one, delivering an average surprise of 3.23%. In the las ...